These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 27852653)

  • 41. Creation of a restrictive atrial left-to-right shunt: a novel treatment for heart failure.
    De Rosa R; Schranz D
    Heart Fail Rev; 2018 Nov; 23(6):841-847. PubMed ID: 30267205
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and Safety of Inter-Atrial Shunt Devices for Heart Failure With Reduced or Preserved Ejection Fraction: Early Experiences.
    Lu D; Zhu J; Liao B
    Heart Lung Circ; 2018 Mar; 27(3):359-364. PubMed ID: 28483550
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hemodynamic Characteristics in Significant Symptomatic and Asymptomatic Primary Mitral Valve Regurgitation at Rest and During Exercise.
    Bakkestrøm R; Banke A; Christensen NL; Pecini R; Irmukhamedov A; Andersen M; Borlaug BA; Møller JE
    Circ Cardiovasc Imaging; 2018 Feb; 11(2):e007171. PubMed ID: 29449412
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of Interatrial Shunt on Pulmonary Vascular Function in Heart Failure With Preserved Ejection Fraction.
    Obokata M; Reddy YNV; Shah SJ; Kaye DM; Gustafsson F; Hasenfuβ G; Hoendermis E; Litwin SE; Komtebedde J; Lam C; Burkhoff D; Borlaug BA
    J Am Coll Cardiol; 2019 Nov; 74(21):2539-2550. PubMed ID: 31753198
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study.
    Guazzi M; Vicenzi M; Arena R; Guazzi MD
    Circulation; 2011 Jul; 124(2):164-74. PubMed ID: 21709061
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardiovascular Effects of Oral Ketone Ester Treatment in Patients With Heart Failure With Reduced Ejection Fraction: A Randomized, Controlled, Double-Blind Trial.
    Berg-Hansen K; Gopalasingam N; Christensen KH; Ladefoged B; Andersen MJ; Poulsen SH; Borlaug BA; Nielsen R; Møller N; Wiggers H
    Circulation; 2024 May; 149(19):1474-1489. PubMed ID: 38533643
    [TBL] [Abstract][Full Text] [Related]  

  • 47. State-of-the-Art Review of Current Therapies for HFpEF: An Overview of Interatrial Septal Device Therapy in Heart Failure.
    Al-Sadawi M; Ortega RR; Ariyaratnam J; Battisha A; Madoukh B; Bukharovich I
    Curr Cardiol Rev; 2021; 17(5):e230421189012. PubMed ID: 33305708
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mean Right Atrial Pressure for Estimation of Left Ventricular Filling Pressure in Patients with Normal Left Ventricular Ejection Fraction: Invasive and Noninvasive Validation.
    Nagueh SF; Smiseth OA; Dokainish H; Andersen OS; Abudiab MM; Schutt RC; Kumar A; Gude E; Sato K; Harb SC; Klein AL
    J Am Soc Echocardiogr; 2018 Jul; 31(7):799-806. PubMed ID: 29580694
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiac and Metabolic Effects of Dapagliflozin in Heart Failure With Preserved Ejection Fraction: The CAMEO-DAPA Trial.
    Borlaug BA; Reddy YNV; Braun A; Sorimachi H; Omar M; Popovic D; Alogna A; Jensen MD; Carter R
    Circulation; 2023 Sep; 148(10):834-844. PubMed ID: 37534453
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Feasibility and efficacy of transcatheter interatrial shunt devices for chronic heart failure: a systematic review and meta-analysis.
    Lauder L; Pereira TV; Degenhardt MC; Ewen S; Kulenthiran S; Coats AJS; Böhm M; Anker SD; da Costa BR; Mahfoud F
    Eur J Heart Fail; 2021 Nov; 23(11):1960-1970. PubMed ID: 34628706
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Isosorbide Dinitrate, With or Without Hydralazine, Does Not Reduce Wave Reflections, Left Ventricular Hypertrophy, or Myocardial Fibrosis in Patients With Heart Failure With Preserved Ejection Fraction.
    Zamani P; Akers S; Soto-Calderon H; Beraun M; Koppula MR; Varakantam S; Rawat D; Shiva-Kumar P; Haines PG; Chittams J; Townsend RR; Witschey WR; Segers P; Chirinos JA
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28219917
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Percutaneous ventricular restoration using the parachute device in patients with ischemic heart failure: three-year outcomes of the PARACHUTE first-in-human study.
    Costa MA; Mazzaferri EL; Sievert H; Abraham WT
    Circ Heart Fail; 2014 Sep; 7(5):752-8. PubMed ID: 25037310
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Left atrial decompression through unidirectional left-to-right interatrial shunt for the treatment of left heart failure: first-in-man experience with the V-Wave device.
    Amat-Santos IJ; Bergeron S; Bernier M; Allende R; Barbosa Ribeiro H; Urena M; Pibarot P; Verheye S; Keren G; Yaacoby M; Nitzan Y; Abraham WT; Rodés-Cabau J
    EuroIntervention; 2015 Jan; 10(9):1127-31. PubMed ID: 24832489
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Physiology of the native heart and Thermo Cardiosystems left ventricular assist device complex at rest and during exercise: implications for chronic support.
    Branch KR; Dembitsky WP; Peterson KL; Adamson R; Gordon JB; Smith SC; Jaski BE
    J Heart Lung Transplant; 1994; 13(4):641-50; discussion 651. PubMed ID: 7947881
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Left Atrial Decompression Using Unidirectional Left-to-Right Interatrial Shunt: Initial Experience in Treating Symptomatic Heart Failure With Preserved Ejection Fraction With the W-Wave Device.
    Amat-Santos IJ; Del Trigo M; Bergeron S; Pibarot P; Altisent O; Campelo-Parada F; Puri R; Verheye S; Keren G; Katzenellenbogen R; Rozenfeld E; Abraham WT; Bernier M; Rodés-Cabau J
    JACC Cardiovasc Interv; 2015 May; 8(6):870-872. PubMed ID: 25999114
    [No Abstract]   [Full Text] [Related]  

  • 56. Obesity in heart failure with preserved ejection fraction: Insights from the REDUCE LAP-HF II trial.
    Litwin SE; Komtebedde J; Seidler T; Borlaug BA; Winkler S; Solomon SD; Eicher JC; Mazimba S; Khawash R; Sverdlov AL; Hummel SL; Bugger H; Boenner F; Hoendermis E; Cikes M; Demers C; Silva G; van Empel V; Starling RC; Penicka M; Cutlip DE; Leon MB; Kitzman DW; van Veldhuisen DJ; Shah SJ;
    Eur J Heart Fail; 2024 Jan; 26(1):177-189. PubMed ID: 37989800
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cavoaortic shunt improves hemodynamics with preserved oxygen delivery in experimental right ventricular failure during left ventricular assist device therapy.
    Vikholm P; Schiller P; Johansson J; Hellgren L
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):625-31. PubMed ID: 23477692
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interatrial Shunt Treatment for Heart Failure: The Randomized RELIEVE-HF Trial.
    Stone GW; Lindenfeld J; Rodés-Cabau J; Anker SD; Zile MR; Kar S; Holcomb R; Pfeiffer MP; Bayes-Genis A; Bax JJ; Bank AJ; Costanzo MR; Verheye S; Roguin A; Filippatos G; Núñez J; Lee EC; Laufer-Perl M; Moravsky G; Litwin SE; Prihadi E; Gada H; Chung ES; Price MJ; Thohan V; Schewel D; Kumar S; Kische S; Shah KS; Donovan DJ; Zhang Y; Eigler NL; Abraham WT;
    Circulation; 2024 Sep; ():. PubMed ID: 39308371
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Percutaneous ventricular restoration (PVR) therapy using the Parachute device in 100 subjects with ischaemic dilated heart failure: one-year primary endpoint results of PARACHUTE III, a European trial.
    Thomas M; Nienaber CA; Ince H; Erglis A; Vukcevic V; Schäfer U; Ferreira RC; Hardt S; Verheye S; Gama Ribeiro V; Sugeng L; Tamburino C
    EuroIntervention; 2015 Oct; 11(6):710-7. PubMed ID: 26499223
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pulmonary Vascular Distensibility Predicts Pulmonary Hypertension Severity, Exercise Capacity, and Survival in Heart Failure.
    Malhotra R; Dhakal BP; Eisman AS; Pappagianopoulos PP; Dress A; Weiner RB; Baggish AL; Semigran MJ; Lewis GD
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27301469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.